Gemcitabine Hydrochloride and Tanespimycin in Treating Patients With Stage IV Pancreatic Cancer
Status:
Completed
Trial end date:
2013-05-01
Target enrollment:
Participant gender:
Summary
This randomized phase II trial is studying three different schedules of gemcitabine
hydrochloride and tanespimycin to see how well they work in treating patients with stage IV
pancreatic cancer. Drugs used in chemotherapy, such as gemcitabine hydrochloride and
tanespimycin, work in different ways to stop the growth of tumor cells, either by killing the
cells or by stopping them from dividing. Giving more than one drug (combination chemotherapy)
may kill more tumor cells